CRH is offering $150 per share for Arcosa, representing a 10.4% premium to Arcosa's last close. Arcosa shares rose 7.4% to $146 in premarket trade.
The deal is expected to close in the first quarter of 2027.
J.P. Morgan and Morgan Stanley are acting as financial advisors to CRH, while Evercore and Goldman Sachs are serving as financial advisors to Arcosa.
<small>Source: CNBC</small>
